Dot1l expression predicts adverse postoperative prognosis of patients with clear-cell renal cell carcinoma

BACKGROUND: Disruptor of telomeric silencing 1-like (Dot1l), a histone methyltransferase that targets the histone H3 lysine 79 (H3K79), has been reported that its high expression is associated with various cancers, while the association between Dot1l expression and clear-cell renal cell carcinoma (c...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Qu, Yang, Liu, Li, Wang, Jiajun, Xi, Wei, Xia, Yu, Bai, Qi, Xiong, Ying, Long, Qilai, Xu, Jiejie, Guo, Jianming
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5356697/
https://ncbi.nlm.nih.gov/pubmed/27713173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12476
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki